 15th June 2015 | ||
| Our pick of today's science stories Philae is awake. The Philae lander has woken up and called home, and now has enough power to start doing science again. The probe lost contact shortly after bouncing awkwardly when it landed on comet 67P back in November. (Nature news story) Water watch. Farmers with rights to California water dating back more than 100 years are being ordered to cut back on their water use as the state battles with severe drought. (Bloomberg) Endangered species. Chimpanzee research in the US may be over: Captive chimps have been categorised as an endangered species subject to legal protections. (Nature news story) Anthrax alarm bells. The US Army research facility that mistakenly sent live anthrax to dozens of labs in the US and abroad (see Nature news story) faced potential sanctions back in 2007 for failing to properly destroy specimens of the bacteria – and ignoring test results that indicated their destruction processes weren't working. (USA Today) PTSD vaccine? Tweaking the immune system could be key to treating, or even preventing, post-traumatic stress disorder. (Nature news story) Precipitation. The remains of NASA's rain-monitoring spacecraft, part of the joint US-Japan Tropical Rainfall Measuring Mission (TRMM), will burn up in Earth's atmosphere tomorrow after 17 years in space collecting data for climate and weather research. (NASA) UK Honours. The Queen's Birthday Honours list has recognised several individuals for their work in science and related fields, including Nature's very own editor-in-chief, Philip Campbell. (Nature news story; Birthday Honours list 2015) Today's good read In the past, a drug under development probably would be written off as a failure if 48 out of 50 patients in a clinical trial experienced little or no benefit. But that left unanswered why a handful of patients had "a Lazarus-like, unbelievable response." Maybe the drugs themselves weren't failures. Maybe they were being given to the wrong patients. If scientists could figure out which genetic wrinkles caused some patients to respond so profoundly to a certain drug, they might be able to find others who would have the same extraordinary reaction. Read more: 'Exceptional responders' to cancer drugs draw scrutiny from scientists in The Washington Post. For more daily science news, check in at www.nature.com/news; @NatureNews on Twitter; or on our Facebook page. This newsletter is new and evolving — tell us what you think! Please send feedback to daily@nature.com. | ||
| Your email address is in the Nature News Daily Alert mailing list. You have been sent this Daily News Alert because you have opted in to receive it. If you no longer wish to receive this alert or to discontinue all e-mail services from Nature Publishing Group please update your online account. Modify My Account (Log in to be recognised as a Nature.com registrant). For further information on technical assistance | print subscriptions | other enquiries Nature Publishing Group | Principal offices: London | New York and Tokyo and offices in cities worldwide including Basingstoke | Barcelona | Boston | Buenos Aires | Cairo | Delhi | Heidelberg | Shanghai | Madrid | Melbourne | Mexico City | Mumbai | Munich | Paris | San Francisco | Sao Paulo | Seoul and Washington DC. Macmillan Publishers Limited is a company incorporated in England & Wales under company number 785998 & whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. Nature Publishing Group | 75 Varick Street, 9th floor | New York | NY 10013-1917 | USA © 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. | ||
No comments:
Post a Comment